iTeos Therapeutics, Inc. (ITOS)

iTeos Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	215	281	392	695	1,642	1,185
Market Cap Growth	-28.39%	-28.39%	-43.60%	-57.70%	38.57%	-
Enterprise Value	-275	-203	-201	-53	745	845
Last Close Price	5.63	7.68	10.95	19.53	46.56	33.82
PE Ratio	-	-	-	7.19	7.66	-
Forward PE	-	-	-	-	10.82	-
PS Ratio	6.51	8.02	31.11	2.60	4.76	-
PB Ratio	0.35	0.48	0.68	1.05	2.97	3.67
P/TBV Ratio	0.48	0.48	0.68	1.05	2.97	3.67
P/FCF Ratio	-	-	-	3.21	-
P/OCF Ratio	-	-	-	3.20	-
EV/Sales Ratio	-	-	-	2.16	-
EV/EBITDA Ratio	-	-	-	3.04	-
EV/EBIT Ratio	-	-	-	3.04	-
EV/FCF Ratio	-	-	-	1.46	-
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	-
Debt / EBITDA Ratio	-	-	-	0.04	0.02	-
Debt / FCF Ratio	-	-	-	-	0.01	-
Asset Turnover	0.05	0.05	0.02	0.33	0.56	-
Quick Ratio	12.35	12.35	13.46	14.66	2.83	22.45
Current Ratio	12.63	12.63	13.76	14.96	2.88	22.64
Return on Equity (ROE)	-23.06%	-23.06%	-18.19%	15.90%	48.98%	-22.45%
Return on Assets (ROA)	-14.47%	-14.47%	-12.97%	9.72%	24.90%	-14.97%
Return on Capital (ROIC)	-16.66%	-16.66%	-14.77%	13.00%	34.73%	-16.58%
Return on Capital Employed (ROCE)	-	-	-	17.90%	42.20%	-
Earnings Yield	-62.51%	-47.91%	-28.75%	13.91%	13.06%	-3.21%
FCF Yield	-46.42%	-35.57%	-27.24%	-16.14%	31.17%	-2.15%
Buyback Yield / Dilution	-13.17%	-13.17%	5.30%	0.02%	-150.49%	-7336.28%

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q